Group items tagged

Health Benefits of Lemon for Rheumatoid Arthritis Lemon is important for rheumatoid arthritis patients because it has anti-inflammatory and antioxidan...

Health Benefits of Devil's Claw for Rheumatoid Arthritis Devil's claw may be beneficial to treat rheumatoid arthritis. One study founds that group of people ...

The NHS claims that it's been able to save taxpayers £1.2 billion in just three years by procuring hundreds of hospital medicines at a better price. The adoption of cheaper versions of a single drug - adalimumab - which is used to treat more than 45,000 patients with rheumatoid arthritis, inflammatory bowel disease and psoriasis, has accounted for about one third of the savings. After the exclusive patent on the drug - originally known as its brand name Humira - expired in 2018, the NHS struck cost-saving deals to bulk-buy generic versions, which have the same quality, safety and efficacy of a branded one. Since then, tens of millions of pounds have been saved by buying cheaper generic versions of other medicines for conditions ranging from severe skin infections to aggressive blood cancers. Four in five medicines prescribed in the NHS are now non-branded, helping the NHS to achieve significant savings while ensuring the continuity of high-quality patient care. NHS chief executive Amanda Pritchard said: "Smart deals by the NHS mean patients are getting the best medicines and taxpayers are getting best value.

Dr Rod Hughes sets out how pharmacists can play a pivotal role in steering people with joint pain towards a prevention programme… Joint health supplements are big business in the UK, with millions of pounds spent over the counter every year. People turn to these supplements for various reasons, but most are seeking relief from the symptoms of arthritis, a group of painful long-term conditions thought to affect around 10 million people in this country. Osteoarthritis (OA) is the most common form of arthritis, affecting around eight million people in the UK. The condition is generally age-related, with joint pain and stiffness developing as the cartilage between the bones gradually wears away. OA changes and the inflammation involved causes difficulty moving and considerable pain. Rheumatoid arthritis (RA) tends to affect younger people and is caused by the body's immune system attacking the joints. As a nation we tend to ignore our joints until they cause us problems, resulting in an increasing number of people taking long-term analgesics to control the pain or needing surgery to repair knees and hips. Treatment guidelines followed by doctors in the UK recommend that people with arthritis are advised to maintain a healthy weight and keep physically active, while strengthening their muscles and protecting any damaged joints during daily activities.

Accord Healthcare is set to expand its manufacturing and production capabilities for high-quality medicines at its Fawdon plant in Newcastle upon Tyne, England, following a new multi-million-pound investment deal with the government. Chancellor of the Exchequer Rachel Reeves launched the new Life Sciences Innovative Manufacturing Fund (LSIMF) and announced the unlocking of a joint £50 million investment deal during her visit to the Fawdon plant on 1 November. Unveiled as part of a new budget, the LSIMF will distribute up to £ 520 million in capital grants aimed at drug and medical technology production. Accord stated that it will allocate the funding towards developing new product lines, including a novel prostate cancer drug and two autoimmune injectables for treating rheumatoid arthritis and gastroenterology indications, as well as expanding its medicines for adjunctive therapy in cancer. With this investment, Accord also plans to create over 50 new skilled jobs to "safeguard the facility's long-term future." Paul Tredwell, executive vice president of Accord Healthcare EMENA, welcomed the announcement and described it as positive news for the medicines manufacturing industry across the UK.

Dr. Graf at IPS offers stem cell therapy for all types of musculoskeletal conditions. This includes degenerative and rheumatoid arthritis, sports injuries, chronic tendonitis, ligament injury, spinal arthritis, degenerative disc disease, back pain and additional painful conditions such as plantar fasciitis. These treatments are outpatient and very low risk.

The Arthritis session uses research frequencies that show arthritis patients experienced relief from pain. They are designed to relieve arthritis pain, improve your quality of life, help you live easier. Imagine what your life would be without arthritis and the things you could do.

For many people who suffer from joint pain, the weather can be a big factor in their pain. While joint pain can be caused by many different things, such as arthritis, injuries, and age, the weather can aggravate and worsen the pain. Several studies have been conducted over the last several years; however, no concrete evidence supports one theory vs. another. That said, let's take a closer look at how weather affects joint pain and what you can do to minimize the discomfort. How Weather Affects Joint Pain It might seem like an old wives' tale, but there is actually some science behind how weather affects joint pain. Temperature Changes The temperature outside can majorly affect how much joint pain you experience. When temperatures drop, your body will get stiffer and more painful joints as the air around them gets colder. During hot days, the air humidity outside may cause swelling and increased inflammation in your joints which could lead to more pain. Pressure Changes Just like a barometer measures changes in atmospheric pressure, so does your body. Pressure changes due to shifts in the atmosphere can affect joint pain because pressure changes directly impact your joints' lubrication levels. When pressure drops and becomes low enough, it can cause extra friction between bones connected by tendons or muscles, resulting in more pain than usual.

Hospitals and healthcare providers across the UK have been notified about the shortage of an anti-inflammatory medicine caused by a manufacturing failure. The Department of Health and Social Care (DHSC) on Friday (3 May) issued a National Patient Safety Alert stating that Erelzi 50mg solution for injection in pre-filled pen will be out of stock from early May until mid-July 2024. "The supply issues have been caused by a manufacturing failure resulting in delays in production and the implementation of global allocations," it said. However, it noted that homecare providers (Alcura, Healthnet and Sciensus) have sufficient stock to supply existing patients until mid/late May 2024. Although Erelzi 50mg pre-filled syringes (PFS) are still available, they cannot support a full increase in demand, the DHSC warned.